UBS Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.3M | Buy |
5,614,651
+3,211,465
| +134% | +$28.8M | 0.01% | 1200 |
|
|
2025
Q1 | $18M | Buy |
2,403,186
+2,162,834
| +900% | +$16.2M | ﹤0.01% | 1876 |
|
|
2024
Q4 | $1.81M | Sell |
240,352
-184,667
| -43% | -$1.39M | ﹤0.01% | 3796 |
|
|
2024
Q3 | $3.23M | Buy |
425,019
+33,534
| +9% | +$255K | ﹤0.01% | 2641 |
|
|
2024
Q2 | $2.42M | Sell |
391,485
-605,070
| -61% | -$3.74M | ﹤0.01% | 2685 |
|
|
2024
Q1 | $5.06M | Buy |
996,555
+311,567
| +45% | +$1.58M | ﹤0.01% | 2179 |
|
|
2023
Q4 | $4.1M | Buy |
684,988
+379,037
| +124% | +$2.27M | ﹤0.01% | 2186 |
|
|
2023
Q3 | $2.17M | Sell |
305,951
-108,883
| -26% | -$771K | ﹤0.01% | 2488 |
|
|
2023
Q2 | $2.92M | Buy |
414,834
+8,954
| +2% | +$63K | ﹤0.01% | 2358 |
|
|
2023
Q1 | $3.39M | Sell |
405,880
-213,548
| -34% | -$1.78M | ﹤0.01% | 2147 |
|
|
2022
Q4 | $7.11M | Buy |
619,428
+439,894
| +245% | +$5.05M | ﹤0.01% | 1572 |
|
|
2022
Q3 | $2.26M | Buy |
179,534
+27,096
| +18% | +$341K | ﹤0.01% | 2267 |
|
|
2022
Q2 | $1.61M | Buy |
152,438
+9,290
| +6% | +$98.2K | ﹤0.01% | 2537 |
|
|
2022
Q1 | $2.33M | Sell |
143,148
-389,502
| -73% | -$6.33M | ﹤0.01% | 2539 |
|
|
2021
Q4 | $7.38M | Buy |
532,650
+194,262
| +57% | +$2.69M | ﹤0.01% | 1777 |
|
|
2021
Q3 | $4.86M | Buy |
338,388
+159,369
| +89% | +$2.29M | ﹤0.01% | 2033 |
|
|
2021
Q2 | $2.83M | Sell |
179,019
-10,397
| -5% | -$164K | ﹤0.01% | 2448 |
|
|
2021
Q1 | $1.93M | Sell |
189,416
-338,457
| -64% | -$3.44M | ﹤0.01% | 2800 |
|
|
2020
Q4 | $3.93M | Sell |
527,873
-909,182
| -63% | -$6.77M | ﹤0.01% | 2057 |
|
|
2020
Q3 | $4.94M | Buy |
1,437,055
+1,278,179
| +805% | +$4.39M | ﹤0.01% | 1729 |
|
|
2020
Q2 | $757K | Sell |
158,876
-4,924,362
| -97% | -$23.5M | ﹤0.01% | 3041 |
|
|
2020
Q1 | $10.2M | Sell |
5,083,238
-405,049
| -7% | -$810K | ﹤0.01% | 1094 |
|
|
2019
Q4 | $18.9M | Buy |
5,488,287
+2,450,478
| +81% | +$8.45M | 0.01% | 1101 |
|
|
2019
Q3 | $8.7M | Buy |
3,037,809
+835,015
| +38% | +$2.39M | ﹤0.01% | 1460 |
|
|
2019
Q2 | $8.35M | Buy |
2,202,794
+1,691,681
| +331% | +$6.41M | ﹤0.01% | 1492 |
|
|
2019
Q1 | $4.16M | Buy |
511,113
+385,569
| +307% | +$3.14M | ﹤0.01% | 1902 |
|
|
2018
Q4 | $1.01M | Buy |
125,544
+13,659
| +12% | +$110K | ﹤0.01% | 2983 |
|
|
2018
Q3 | $854K | Buy |
111,885
+48,646
| +77% | +$371K | ﹤0.01% | 3278 |
|
|
2018
Q2 | $362K | Sell |
63,239
-228,140
| -78% | -$1.31M | ﹤0.01% | 3759 |
|
|
2018
Q1 | $1.39M | Buy |
291,379
+191,157
| +191% | +$912K | ﹤0.01% | 2790 |
|
|
2017
Q4 | $493K | Sell |
100,222
-13,892
| -12% | -$68.3K | ﹤0.01% | 3470 |
|
|
2017
Q3 | $598K | Buy |
114,114
+50,635
| +80% | +$265K | ﹤0.01% | 3337 |
|
|
2017
Q2 | $353K | Sell |
63,479
-8,562
| -12% | -$47.6K | ﹤0.01% | 3575 |
|
|
2017
Q1 | $605K | Sell |
72,041
-27,762
| -28% | -$233K | ﹤0.01% | 3161 |
|
|
2016
Q4 | $632K | Buy |
99,803
+11,547
| +13% | +$73.1K | ﹤0.01% | 3144 |
|
|
2016
Q3 | $389K | Buy |
88,256
+4,086
| +5% | +$18K | ﹤0.01% | 3299 |
|
|
2016
Q2 | $239K | Buy |
84,170
+11,335
| +16% | +$32.2K | ﹤0.01% | 3648 |
|
|
2016
Q1 | $206K | Sell |
72,835
-68,568
| -48% | -$194K | ﹤0.01% | 3765 |
|
|
2015
Q4 | $1.46M | Buy |
141,403
+69,068
| +95% | +$713K | ﹤0.01% | 2431 |
|
|
2015
Q3 | $825K | Buy |
72,335
+2,651
| +4% | +$30.2K | ﹤0.01% | 2790 |
|
|
2015
Q2 | $1.04M | Sell |
69,684
-200
| -0.3% | -$2.99K | ﹤0.01% | 2772 |
|
|
2015
Q1 | $631K | Sell |
69,884
-690
| -1% | -$6.23K | ﹤0.01% | 3068 |
|
|
2014
Q4 | $858K | Buy |
+70,574
| New | +$858K | ﹤0.01% | 2818 |
|